By Sheeba M.
The Shift From License Arbitrage to Brand Arbitrage
Cannabis entered markets as a commodity. You got the license, you sold cannabis. Retail location didn’t matter much—anyone with a license could move product.
That era is over.
Brands Now Command Price Premiums
An independent cultivator with a cult-following strain can charge 30% premium over commodity product. That’s not regulatory moat—that’s brand moat.
Verano’s Cake brand does $8-10M revenue annually across just 40 locations. Pure-play Surterra operates 180+ locations at lower per-store productivity.
That’s brand power.
Who Controls the Legacy Strains
The independent cultivators who preserved genetics from pre-legalization markets own enormous IP optionality. Ghost OG, Girl Scout Cookies, Granddaddy Purple—these strains command persistent consumer preference.
When GTI or CURLF acquire these cultivators, they’re buying the genetics library, not just the equipment.
The IP Licensing Future
By 2028, cannabis operators will earn 15-20% of gross profit from IP licensing. One cultivator licenses their genetics to three regional operators. Cultivator gets royalties. Operators get premium brand justification.
That’s the target M&A model for independent seed-to-sale operators.
Watch: Organigram‘s brand strategy closely. They own legacy strains from Canadian operations. That’s their moat vs larger MSOs with commodity brands.
TL;DR: Brands matter more as retail consolidates. Trulieve, Surterra, Verano control 60% of national mind-share. Independent cultivators building legacy strains = next acquisition targets. IP licensing will drive 20%+ of operator margins by 2028.